Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: A double blind study
Tóm tắt
Thirty-two patients were entered into a double blind trial of antiemetic support in patients being treated with cisplatin. Patients were allocated to receive either oral nabilone (1 mg 8 hourly) or intravenous metoclopramide (1 mg kg−1 3 hourly) in random order over 4 courses. There was no difference between the two treatments in the overall incidence or severity of vomiting, although a subgroup of patients enjoyed a substantial reduction in episodes of vomiting whilst receiving metoclopramide. Side-effects were predictable from the pharmacology of the drugs.
Tài liệu tham khảo
Trounce J R: Antiemetics and cytotoxic drugs.Br Med J 286, 327 (1983).
Gralla R J, Itri L M, Pisko S E: Antiemetic efficacy of high dose metoclopramide.New Engl J Med 305, 905 (1981).
Herman T S, Einhorn L H, Jones S Eet al: Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.New Engl J Med 300, 1295 (1979).
Siegel S: The Kolmagorov-Smirnov two-sample test, in Siegel S:Nonparametric Statistics for the Behavioral Sciences, pp. 127–136. New York, McGraw-Hill (1956).
Gralla R J, Tyson L B, Bordin L Aet al: Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.Cancer Treat Rep 68, 163 (1984).
Kriss M G, Gralla R J, Tyson L B, Clark R A: Antiemetics and cytotoxic drugs.Br Med J 287, 334 (1983).
Meyer B K, Reidenberg M M, Drayer D E, Pasmantier M, Lewin M: Initial trial of metoclopramide and nabilone combination antiemetic therapy.Clin Res 32, 688A (1984).
Tyson L B, Gralla R J, Clark R A, Kris M G: Combination antiemetic trials with metoclopramide.Proc Am Soc Clin Onc 2, 91 (1983).